Cidara Therapeutics Rises, Stubhub Sinks, Warner Brothers-Discovery Rises on News of Auction
On this episode of Stock Movers:- Cidara Therapeutics (CDTX) shares rise after Merck agreed to acquire Cidara Therapeutics for $221.50 a share in cash in a tender offer, for a total transaction value of about $9.2 billion. Merck is seeking deals to expand its portfolio of treatments as it prepares for patent losses that are expected to erode its sales over the next five years, including a patent expiration for Keytruda in 2028.- Stubhub shares tumble as much as 31% on Friday, with analysts surprised that the ticketing platform did not provide a forecast for the current quarter. This is the firm’s first quarterly report after going public in September. Bank of America downgraded the stock to neutral, as the call commentary and lack of 4Q guidance “added estimate uncertainty.”- Warner Brothers-Discovery (WBD) shares rise after WSJ report that Warner Bros. Discovery is holding an auction process, with Paramount, Comcast, and Netflix preparing bids, according to people familiar with the matter.See omnystudio.com/listener for privacy information.
--------
4:03
--------
4:03
Merck Drops, Walmart Falls, Nvidia Shares Set for Decline Ahead of Earnings
On this episode of Stock Movers:- Merck (MRK) shares drop after the company agreed to acquire Cidara Therapeutics in a $9.2 billion deal, which is a biotech company developing a flu treatment. Merck will pay $221.50 a share in cash for Cidara in a tender offer, more the twice Thursday’s closing price.- Walmart (WMT) shares fall after Walmart CEO Doug McMillon said he will retire in February and be replaced by John Furner. Furner has been long viewed as an heir apparent for McMillon and runs the company’s largest business in the US.- Nvidia (NVDA) shares are little changed. It's set for 2 weeks of declines, the longest streak since early September. Nvidia earnings are next week and over the past year have often been a catalyst to sell; particularly 3-5 days after the event.See omnystudio.com/listener for privacy information.
On this episode of Stock Movers:- Shares of biotech company Cidara Therapeutics (CDTX) surged as much as 106% in premarket trading after Merck agreed to buy the biotech for $221.50 per share in cash, for a total transaction value of about $9.2 billion. Merck is seeking deals to expand its portfolio of treatments as it prepares for patent losses that are expected to erode its sales by $18 billion over the next five years. In 2028, Merck faces a patent expiration for Keytruda, the best-selling drug in pharmaceutical history which accounted for almost half of the company’s revenue last year.- Stubhub (STUB) shares tumble as much as 20% in premarket trading on Friday as analysts note that it was surprising that the ticketing platform did not provide a forecast for the current quarter. This is the firm’s first quarterly report after going public in September. - Warner Bros. Discovery (WBD) shares rallied ahead of the US market open following a Wall Street Journal report that Paramount, Comcast and Netflix are preparing bids for the media giant. WBD amended the contract of Chief Executive Officer David Zaslav to ensure his stock options remain eligible to vest even if the media company is sold. The change, announced in a regulatory filing Thursday, follows the company’s decision last month to consider strategic options including a possible sale.See omnystudio.com/listener for privacy information.
On this episode of Stock Movers:- Shares of Applied Materials (AMAT) tumbled in premarket trading after the company suffered a sales decline last quarter and predicted another drop in the current period, though the chip-equipment maker sees demand improving in the second half of 2026. Sales will be approximately $6.85 billion in fiscal first quarter, which runs through January, the company said in a statement Thursday. Though that was slightly higher than the $6.81 billion average estimate, it would represent a decline of more than 4% from the year-earlier period.- Warner Bros. Discovery (WBD) shares edged higher in premarket trading following a Wall Street Journal report that Paramount, Comcast and Netflix are preparing bids for the media giant. WBD amended the contract of Chief Executive Officer David Zaslav to ensure his stock options remain eligible to vest even if the media company is sold. The change, announced in a regulatory filing Thursday, follows the company’s decision last month to consider strategic options including a possible sale.- Shares of Merck (MRK) moved lower ahead of the US market open after word the company is closing in on a deal to acquire Cidara Therapeutics Inc., a biotech company developing a treatment for influenza, according to the Financial Times. The deal would value San Diego-based Cidara at a premium to its current valuation of $3.3 billion and could be announced as soon as Friday, the newspaper reported.See omnystudio.com/listener for privacy information.
On this episode of Stock Movers:- Richemont sales climbed as shoppers from the US to China snapped up the luxury group’s pricey Cartier and Van Cleef & Arpels jewelry.- PPHE Hotel Group's biggest shareholders are considering options for the real estate company behind Park Plaza Hotels in Europe, including contributing capital or selling some of their stakes. - Ubisoft decided to delay the publication of its first-half financial results on the day that they were due to be released, requesting hat the trading of its shares be halted.See omnystudio.com/listener for privacy information.
Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.
Netherlands